{"groups":[{"description":"Metastatic colorectal cancer (CRC) defined as histologically and/or cytologically confirmed CRC, and must have received at least 1 prior regimen for advanced/metastatic disease.","id":"FG000","title":"Colorectal Cancer"},{"description":"High grade serous ovarian cancer (HGSOC) defined as histologically confirmed high grade serous ovarian, fallopian tube or primary peritoneal cancer who were recurrent platinum intolerant, or with platinum resistant disease defined as radiological evidence of disease progression within 6 months of the last receipt of platinum based chemotherapy.","id":"FG001","title":"High Grade Serous Ovarian Cancer"},{"description":"Advanced non small cell lung cancer (NSCLC) defined as locally advanced and recurrent or metastatic, histologically confirmed NSCLC, and must have received at least 1 prior regimen for advanced/metastatic disease.","id":"FG002","title":"Non Small Cell Lung Cancer"},{"description":"Metastatic castration resistant prostate cancer (mCRPC) defined as histologically or cytologically confirmed adenocarcinoma of the prostate that has progressed after androgen deprivation therapy.","id":"FG003","title":"Metastatic Other Tumor Type Castration Resistant Prostate Cancer"},{"description":"Histologically confirmed HNSCC from any primary site; locally advanced disease (ie, persistent or progressive disease following curative intent radiation, and not a candidate for surgical salvage due to incurability or morbidity), or metastatic disease.","id":"FG004","title":"Head and Neck Squamous Cell Carcinoma"},{"description":"Any locally advanced or metastatic, histologically or cytologically proven solid tumor or NHL, that had relapsed after or progressing despite conventional treatment for which no conventional therapy was considered appropriate by the investigator or had been declined by the subject.","id":"FG005","title":"Other Tumor Type"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"32"},{"groupId":"FG001","numSubjects":"37"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"16"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"8"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"32"},{"groupId":"FG001","numSubjects":"37"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"16"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"8"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}